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Abstract (Chapter 2) 
 
Title: The Microbial Burden and Antibiotic Profile of Pediatric Bacterial Urinary Tract Infections 
at a Tertiary Hospital in the Western Cape, South Africa 
 
Background: Urinary tract infection (UTI) is a commonly encountered problem in infants 
presenting to emergency units with fever. Current international data reports that uropathogens 
and their associated antibiotic susceptibly is evolving. This study describes the organism 
profile and inherent antibiotic resistance pattern at a tertiary hospital in the Western Cape, 
South Africa 
 
Methods: A retrospective study on all urine samples sent to the National Health Laboratory 
Service (NHLS) from 1 January 2012 – 31 December 2013 at Tygerberg Hospital was 
performed. UTI was defined as a single organism growth >105 cfu/ml and leukocytes >1000 
cells/ml. The organisms and antibiotic sensitivities were described and further correlated with 
community, hospital associated or hospital acquired infections, HIV status and blood culture 
results were also determined. 
 
Results: 282 samples met study definitions for inclusion in the study. E. coli was cultured 
most frequently (143/50.7%) followed by K. pneumoniae (64/22.7%) and P. mirabillis 
(13/4.6%). Extended spectrum beta lactamase (ESBL) producing organisms accounted for 
75/64.1%; K. pneumoniae accounted 54/72% of those infections. Most ESBL infections were 
hospital acquired (32/42.7%). For E. coli, 90.8% were resistant to amoxicillin/ampicillin and 
71.8% to TMP/SMX. For K. pneumoniae, 88.7% were resistant to co-amoxiclavulanic acid and 
98.2% to cefotaxime/ceftriaxone. HIV status was not predicative of more resistant organisms; 
the numbers in the HIV group were too small to be statistically significant. 
 
Conclusion: The organism population and antibiotic sensitivity profile is evolving in line with 
international data trends. Of ESBL-producing organisms, 1/6.7% of E. coli were sensitive to 
piperacillin-tazobactam and and 5/33.3% to amikacin. K. pneumoniae displayed 10/18.5% and 
37/68.5% sensitivity to piperacillin-tazobactam and amikacin respectively. These antibiograms 
support current hospital policy to treat hospital associate and acquired infections with 
piperacillin-tazobactam and amikacin empirically until urine culture and sensitivity are 
available thereby limiting carbapenem drug pressure. Further data is required looking at the 
influence of HIV of UTI and risk factors for the development of resistance 
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Opsomming (hoofstuk 2) 
 
Titel: Die Mikrobiese Lading en Antibiotiese Profiel van Pediatriese Bakteriese 
Urienweginfeksies by ’n Tersiêre Hospitaal in die Wes-Kaap, Suid-Afrika 
 
Agtergrond: Urienweginfeksie (UWI) is ’n algemene probleem by babas wat met koors in die 
noodeenheid beland. Volgens huidige internasionale data evolueer uropatogene en die 
gepaardgaande antibiotiese vatbaarheid daarvan voortdurend. Hierdie studie beskryf die 
organismeprofiel en inherente antibiotiese weerstandspatroon by pediatriese UWI-pasiënte in 
’n tersiêre hospitaal in die Wes-Kaap, Suid-Afrika. 
 
Metodes: ’n Retrospektiewe studie is uitgevoer met alle urinemonsters wat van 
1 Januarie 2012 tot 31 Desember 2013 na die Nasionale Gesondheidslaboratoriumdiens 
(NHLS) by Tygerberghospitaal gestuur is. UWI is omskryf as ’n enkele organisme met ’n 
groeitempo van >105 cfu/ml en ’n leukosietsyfer van >1 000 selle/ml. Die organismes en 
antibiotiese sensitiwiteit is beskryf en verder gekorreleer met gemeenskaps-, 
hospitaalverwante en hospitaalverworwe infeksies, MIV-status en bloedkwekingsresultate. 
 
Resultate: Altesaam 282 monsters het aan die vereistes vir insluiting by die studie voldoen. 
E. coli is die gereeldste gekweek (143/50,7%), gevolg deur K. pneumoniae (64/22,7%) en 
P. mirabillis (13/4,6%). Organismes wat uitgebreidespektrum-beta-laktamase (ESBL) 
produseer, was verantwoordelik vir 75/64,1% van die infeksies, en K. pneumoniae vir 54/72%. 
Die meeste ESBL-infeksies was hospitaalverworwe (32/42,7%). E. coli was 90,8% 
weerstandig teen amoksisillien/ampisillien, en 71,8% teen TMP/SMX. K. pneumoniae was 
onderskeidelik 88,7% en 98,2% weerstandig teen ko-amoksiklavulaansuur en 
kefotaksiem/keftriaksoon. MIV-status was nie ’n aanwyser van weerstandiger organismes nie; 
die getalle in die MIV-groep was te laag om statisties beduidend te wees. 
 
Gevolgtrekking: Die organismepopulasie en antibiotiese sensitiwiteitsprofiel evolueer in pas 
met tendense in internasionale data. Onderskeidelik 1/6.7% en 5/33.3% van die UWI-gevalle 
in hierdie studie wat met ESBL-E. coli verband gehou het, was sensitief vir piperasillien-
tazobaktam en amikasien. K. pneumoniae het in onderskeidelik 10/18,5% en 37/68,5% van 
gevalle sensitiwiteit vir piperasillien-tazobaktam en amikasien getoon. Hierdie antibiogramme 
ondersteun huidige hospitaalbeleid om hospitaalverwante en -verworwe infeksies empiries 
met piperasillien-tazobaktam en amikasien te behandel totdat urinekweking en -sensitiwiteit 
beskikbaar is, om sodoende karbapenem-middeldruk te beperk. Verdere data oor die invloed 
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Abstract (Chapter 3) 
 
Title: Factors Impacting Positive Urinary Tract Infections in patients (0-5 years) Attending a 
Paediatric Emergency ward in a Tertiary Care Hospital in the Western Cape, South Africa 
 
Background: Urinary tract infection (UTI) is a commonly encountered problem in infants with 
fever presenting to emergency units. This study evaluated factors (clinical signs, antibiotic 
exposure and co-morbid conditions) that influence positive urine cultures in patients 
presenting to the emergency center at a tertiary hospital in the Western Cape, South Africa. 
Furthermore, the correlation with urine dipsticks, serum inflammatory marker, and renal 
imaging studies and UTI was described. 
 
Methods: A convenience sample of children (birth-5 years) presenting to the emergency unit, 
in whom urine samples were submitted, were prospectively enrolled into the study provided 
informed individual consent was obtained from the parent/guardian. Patients and caregivers 
were interviewed using preformed data collections sheets. Patient were further subdivided into 
those < 3 and > 3 months old; casualty protocols dictate that patients < 3 months old have 
urine dipsticks +/- formal urine analysis when screening for sites of potential bacterial sepsis. 
 
Results: One hundred and twenty-three samples were included in the study. Twenty-nine 
(23.6%) samples had culture confirmed UTI and 34 (27.6%) had mixed organism growth on 
urine culture. E. coli was isolated in 12 (41.4%) followed by Klebsiella pneumoniae in 9 (31%) 
cases. E. coli and K. pneumoniae showed sensitivity rates to ciprofloxacin of 91.7% and 100% 
respectively. Patients with severe acute malnutrition and acute respiratory tract infections 
were less likely to have UTI. HIV exposure (this group is over represented in our setting) 
(p=0.044) and urine leukocyte esterase and nitrates (p=0.018 and p=0.043 respectively) were 
significantly related with culture confirmed UTI. Renal ultrasound imaging was likely to be 
normal in patients with confirmed UIT (p=0.0). 
 
Conclusion: Twenty-nine (23.6%) urine samples were positive for a urine pathogen. This is 
markedly higher than international trends. HIV exposure and urine dipsticks were statistically 
significant for correlating with culture confirmed UTI. These factors must be considered to 
guide empiric antibiotic administration. Of our cohort, 27.6% of samples were mixed growth, 
indicating how difficult it is to obtain sterile specimesn from apediatric patients. These 
specimesn were not repeated and therefore clinically significant true UTI was missed. 
Furthermore, these samples should be repeated if clinically indicated as missed UTI can lead 
to significant patient morbidity. 
Stellenbosch University  https://scholar.sun.ac.za
VII 
Opsomming (hoofstuk 3) 
 
Titel: Faktore met ’n Invloed op Positiewe Kwekings vir Urienweginfeksie by Pasiënte 
(0 tot 5 jaar) in ’n Pediatriese Noodeenheid in ’n Tersiêresorghospitaal in die Wes-Kaap, Suid-
Afrika 
 
Agtergrond: Urienweginfeksie (UWI) is ’n algemene probleem by babas wat met koors in die 
noodeenheid beland. Hierdie studie het faktore (kliniese tekens, antibiotiese blootstelling en 
ko-morbiede omstandighede) beoordeel wat ’n invloed het op positiewe urinekwekings by 
pediatriese pasiënte in die noodeenheid van ’n tersiêre hospitaal in die Wes-Kaap, Suid-
Afrika. Daarbenewens is die korrelasie tussen UWI en urinedoopstokkies, 
seruminflammasiemerkers en nierbeeldingstudies beskryf. 
 
Metodes: ’n Geriefsteekproef van kinders (pasgebore tot 5 jaar oud) wat in die noodeenheid 
beland het en van wie urinemonsters ingesamel is, is voorlopig in die studie opgeneem, met 
dien verstande dat hulle ouer/voog se ingeligte individuele toestemming verkry word. 
Onderhoude is met behulp van voorafopgestelde data-insamelingsvelle met pasiënte en hulle 
versorgers gevoer. Pasiënte is ook ingedeel in diegene jonger as drie maande en diegene 
ouer as drie maande; volgens ongevalleprotokol moet pasiënte jonger as drie maande ’n 
urinedoopstokkietoets en/of formele urine-ontleding ondergaan om moontlike bakteriese 
sepsis op te spoor. 
 
Resultate: Altesaam 123 monsters het aan die vereistes vir insluiting by die studie voldoen. 
Van daardie pasiënte het 29 (23,6%) kwekingsbevestigde UWI gehad, en 34 (27,6%) 
gemengde organismegroei in die urinekweking. E. coli is in 12 (41,4%) gevalle geïsoleer, 
gevolg deur Klebsiella pneumoniae in nege (31%) gevalle. E. coli en K. pneumoniae was 
onderskeidelik 91,7% en 100% sensitief vir siprofloksasien. Die waarskynlikheid van UWI by 
pasiënte met erge akute wanvoeding en akute lugweginfeksies was kleiner. MIV-blootstelling 
(hierdie groep is oorverteenwoordig in ons omgewing) (p = 0,044) en leukosiet-esterase en 
nitrate in die urine (p = 0,018 en p = 0,043 onderskeidelik) was statisties beduidend vir 
korrelasie met kwekingsbevestigde UWI. Die waarskynlikheid van normale 
nierultraklankbeelding by pasiënte met bevestigde UWI was hoog (p = 0,0). 
 
Gevolgtrekking: Altesaam 29 (23,6%) van die urinemonsters het positief getoets vir ’n 
urinepatogeen. Dít is merkbaar hoër as internasionale tendense. MIV-blootstelling en 
urinedoopstokkies was statisties beduidend vir korrelasie met kwekingsbevestigde UWI. 
Hierdie faktore moet as rigsnoere vir die empiriese toediening van antibiotika beskou word. ’n 
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Totaal van 27,6% van die monsters uit ons kohort het gemengde groei getoon. Hieruit blyk 
duidelik hoe moeilik dit is om steriele monsters by pediatriese pasiënte te verkry. Hierdie 
uriene monsters is nie herhaal nie en daarem was kliniese beduidende UWI gemis. Monsters 
moet herhaal word indien daar kliniese indikasies bestaan, aangesien UWI wat misgekyk word 




















































Dr C. du Buisson, thank you for your kindness and encouragement throughout these past 4 
years in helping me complete my dissertation. 
 
Prof. H. Rabie, thank you for your continued guidance, patience and expertise to let me find 
my feet in the world of research. 
 
A final acknowledgement to Dr A. Dramowski, Mr. M. Chirehwa and the staff in G-ground, 



































To my wife and parents, your fierce belief and support of me in pursuit of my dreams is a 
kindness and strength that I will never adequately be able to describe. 
 
“Have I not commanded you? Be strong and courageous. Do not be afraid; do not be 
discouraged, for the LORD your GOD will be with you wherever you go.” 
































Stellenbosch University  https://scholar.sun.ac.za
XI 
Table of Contents 
 
I. Declaration         II 
II. Abstract/Opsomming        III-VIII 
III. Acknowledgments         IX 
IV. Dedications         X 
V. Table of Contents        XI-XII 
VI. List of Figures and Tables        XIII 
VII. Abbreviations          XIV 
1. Chapter 1: An Overview of Paediatric Urinary Tract Infection 
i. Epidemiology        p1-2 
ii. Microbiology        p2 
iii. Pathophysiology       p2 
iv. Diagnosis        p2-3 
v. Management in an Era of Increasing Resistance   p3-4 
vi. Comorbid Conditions       p4-5 
vii. Rational for further Investigation     p5 
viii. References         p5-7 
2. Chapter 2: The Microbial Burden and Antibiotic Profile of Paediatric Bacterial 
Urinary Tract Infections at a Tertiary Hospital in the Western Cape, South Africa 
i. Introduction         p8-9 
ii. Definitions         p9 
iii. Material and Methods       p10-11 
a. Setting        p10 
b. Study Design        p10 
c. Investigation of UTI      p10-11 
d. Statistical Analysis       p11 
e. Ethics         p11 
iv. Results         p12-16 
v. Discussion        p17-19 
vi. Conclusion         p19 
vii. Funding and Conflict of Interest     p19 
viii. References         p19-21 
 
 
Stellenbosch University  https://scholar.sun.ac.za
XII 
3. Chapter 3: Factors Impacting Positive Urinary Tract Infections in patients (0-5 
years) Attending a Paediatric Emergency ward in a Tertiary Care Hospital in the 
Western Cape, South Africa 
i. Introduction         p22-23 
ii. Material and Methods       p23-24 
a. Setting        p23 
b. Study Design and Data Management    p24 
c. Statistical Analysis       p24 
d. Ethics         p24 
iii. Results        p25-30 
iv. Discussion         p31-33 
v. Conclusion         p33 
vi. Funding and Conflict of Interest     p34 
vii. References        p34-35 
4. Chapter 4: Conclusion – a Unifying Discussion    p36-38 
5. Appendix A: Informed Individual Consent form (study “Factors Impacting 
Positive Urinary Tract Infections in patients (0-5 years) Attending a Paediatric 
Emergency ward in a Tertiary Care Hospital in the Western Cape, South Africa”) 
………………………………………………………………………………………p39-42 
6. Appendix B: Data Collection Sheet (study “Factors Impacting Positive Urinary 
Tract Infections in patients (0-5 years) Attending a Paediatric Emergency ward 
















Stellenbosch University  https://scholar.sun.ac.za
XIII 
List of Figures and Tables 
 
Chapter 2: 
i. Figure 1: Patient Recruitment Algorithm      p12 
ii. Table1: Total and Specific Uropathogen Demographic Data   p14 
iii. Table 2: In-vitro Resistance to tested Antibiotics     p15 
iv. Table3: Uropathogen Antibiotic Category Resistance    p16 




i. Figure 1: Patient Recruitment Algorithm      p25 
ii. Table1: Demographic Data for Study Population, < 3months old and > 3months old 
p28 
iii. Table 2: Variable (history, co-morbidities and antibiotic exposure) and the Influence 
of UTI in the Study Population       p29 



























UTI: Urinary tract infection 
NHLS: National Health Laboratory Service 
HIV: Human immunodeficiency virus 
CFU: Colony forming unit 
MSU: Midstream urine 
CRP: C-reactive protein 
TMP/SMX: Trimethoprim/Sulphamethoxazole 
VUR: Vesicoureteric reflux 
MDR: Multi-drug resistance 
XDR: Extreme drug resistance 
ESBL: Extended spectrum B-lactam 
IBL: Inducible B-lactam 
KUB US: Kidney Ureter Bladder Ultrasound 






























Stellenbosch University  https://scholar.sun.ac.za
1 
Chapter 1: An Overview of Paediatric Urinary Tract Infection 
 
Epidemiology: 
Urinary tract infections (UTI) are an important consideration in all children presenting to an 
emergency unit with unexplained pyrexia(1). UTI is defined as the presence of a uropathogen 
in the urinary tract resulting in symptoms, signs with or without deranged inflammatory 
markers (2). It differs from asymptomatic bacteriuria, which indicates colonization of the 
urinary tract and requires no treatment. UTIs are classified into infections of the lower (urethra 
and bladder) and upper (ureter, renal pelvis and renal parenchyma) urinary tract. This 
distinction has implications on initial management, investigation and follow-up (1,2). Infections 
of the upper tract are termed pyelonephritis.  
 
Lower tract infections are generally treated as simple infections. However, upper tract 
infections, especially if recurrent, have significant morbidity and mortality. They may lead to 
acute kidney injury (especially in neonates and infants) renal scarring, hypertension, 
renal/perinephric abscesses, bacteraemia with systemic inflammation and chronic renal 
disease (1–3). Recurrence of UTI is a recognised complication with higher rates amongst 
those patients experiencing their first infection after the age of 1 year. Boys have a recurrence 
rate of 32% compared to girls at 40%. Each prior infection increases the inherent risk by 25% 
(1). 
 
A meta-analysis on the prevalence of UTI showed that rates vary by age, gender, race and 
circumcision status (4,5). UTI is more common amongst pre-school children compared to 
school-age children with rates of 1-3% and 0.7-2.3% respectively(1). The overall incidence is 
6.6-8% of girls and 2% of boys by the age of 7 years (1,6). Furthermore, 5-14% of emergency 
room visits by children can be attributed to UTI (4). Shaik et al conducted a metanalysis and  
found that the prevalence rates of UTI in 2008 were higher compared to a study conducted by 
the American Academy of Paediatrics in 1999. Females with fever have higher rates of UTI in 
the first year of life and these decline over the following 2 years: 7.5% (0-3 months), 5.7% (3-
6 months), 8.3% (6-12 months) and 2.1% (>12 months) (5).  
 
Circumcision reduces to the incidence of UTI by 90% in normal boys (4). The prevalence of 
UTI in circumcised compared to uncircumcised infants is 2.4% and 20.1% respectively (5). 
Although randomised controlled trials are required to show the efficacy of circumcision in 
reducing the rate of UTI in children with urinary tract abnormalities, it can be considered a 
therapeutic intervention in this setting (4). There is emerging controversy surrounding routine 
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Current international research shows that the microbiological profiles in lower and upper 
urinary tract infections are similar. Escherichia coli (E. coli) is the most common uropathogen, 
found in 90% of culture positive samples. Other organisms identified from community acquired 
UTI are Enterobacter aerogenes, Enterococcus species, Proteus vulgaris, Proteus mirabilis, 
Pseudomonas aeruginosa, Klebsiella pneumoniae and Klebsiella oxytoca (6–9). A 
retrospective study conducted by Mirsoleymani et al showed that gender influences the 
microbial profile. E. coli is more common amongst females whereas Klebsiella spp. infections 
are more likely to occur in in males (10). 
 
Pathophysiology: 
The pathophysiology has been well described with structural and physiological abnormalities 
predisposing to infection. Unidirectional flow of urine, Tamm-Horsfall proteins and immune 
function are important in preventing UTI. These mechanisms interact with bacterial adhesion 
molecules and virulence properties to prevent ascending infection (2,11). Haematological 
spread from skin lesions, abscesses and cardiac vegetations are also implicated but are rare. 
Indwelling catheters are associated with an increased incidence of hospital associated and 
hospital acquired urinary tract infections (12). This has been attributed to the development of 
a bacterial biofilm inherent to long term catheter use. The bacteria become integrated into the 
catheter and tissue; quorum sensing allows for modulation gene responses coding for 
antibiotic targets thereby increasing their resistance profile (12).  
 
Clinical assessment of UTI is difficult as younger patients are unable to voice their symptoms. 
Older children may complain of dysuria, frequency, vomiting, rigors, fever and flank/loin pain. 
A fever >380C and irritability in infants and toddlers are highly suggestive signs of 
pyelonephritis (1). Inflammatory markers are able to predict the site of infection. Elevated 
procalcitonin (PCT) levels have a sensitivity and specificity of 94.1% and 89.7% respectively 
for the diagnosis of acute pyelonephritis (3). C-reactive protein (CRP) has a sensitivity of 100% 
and specificity of 18.5% (3). 
 
Diagnosis: 
In emergency units, rapid reagent urinary dipsticks are readily available. Zorc et al conducted 
a meta-analysis of various modalities commonly used in UTI diagnosis. Leukocyte esterase 
has a sensitivity of 83% and specificity of 84%. Nitrates are not very sensitive (50%) but are 
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highly specific 98% (2). The gold standard for diagnosing a UTI is a positive urine culture. 
Specimens must be collected in a sterile manner using a midstream urine collection, 
suprapubic aspiration or sterile catheter. Single organism growth of >104 CFU/ml from a sterile 
catheter collection is considered positive, whilst any growth from a suprapubic aspirate can 
be considered positive (2). Microscopy with gram stain has a sensitivity of 93% and specificity 
of 95% for UTI (2). Standard microscopy showing >5 white cells/high powered field has a 
sensitivity of 67% and specificity of 79% (2). 
 
Clinical practice guidelines published by the American Academy of Paediatrics noted that 
culture from urine [perineal] bags have a worryingly high rate of false positives: approximately 
88% (13). This has significant implications for patients as unsterile cultures lead to 
unnecessary hospital admissions, investigations and antibiotic use, therefore predispose to 
antibiotic resistance. 
 
Management in an Era of Increasing Resistance 
There is a paucity of South African paediatric data on the organism profile in UTI. Published 
results relate to adult female patients and correlate with international paediatric data. E. Coli 
is the most common organism isolated amongst adult patients. The other urinary isolates 
occurred in various frequencies (14,15). In a study published in 1994, Maartens and Oliver 
found that the incidence of antibiotic resistance to amoxicillin (65.1%) and co-trimoxazole 
(47.3%) amongst urinary isolates was present amongst community-acquired infections in 
Cape Town (16). 
 
A study by Habte et al in 2009 examined urinary isolates in hospital and community isolates 
in adult patients and found that gram-negative pathogens had a high level of resistance to 
amoxicillin (43-100%) and co-trimoxazole (29-90%). Resistance to gentamicin (0-50%) and 
ciprofloxacin (0-33%) was lower. Importantly, extended-spectrum beta lactamase (ESBL) 
organisms were more prevalent in hospital patients (15). In 2013, Lewis et al showed similar 
results amongst adult female patients with high levels of resistance to co-amoxiclavulinic acid 
(82.8% CI 77.5-88) when compared to fluoroquinolones and fosfomycin. Furthermore, 
trimethoprim/sulphamethoxazole (TMP/SMX) was the least effective agent in the treatment of 
UTI (44.3% susceptible; CI 37.4-51.2) (14). 
 
When comparing these South African results to international data, a similar trend of resistance 
to TMP/SMX, amoxicillin and co-amoxiclavulinic acid is apparent. In addition, increasing 
resistance to cephalosporins amongst E. coli isolates has been observed. Fortunately, 
nitrofurantoin remains an efficacious agent in the treatment of UTI (7,8,17,18). A study in North 
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India showed in-vitro resistance to imipenem amongst Enterobacteriaceae. Enterococci were 
more common amongst nosocomial UTI and 12% of those strains were vancomycin resistant 
(9).  With the widespread, often indiscriminate use of antibiotics, one can postulate that rates 
of resistance have increased over the last two decades and that updated paediatric data in 
South Africa is a necessity as this is a complex eveolving issue. 
 
Nosocomial infections are associated with increased morbidity, mortality and health care cost, 
comprising 10% of hospital acquired infections amongst children (19,20). Prolonged indwelling 
catheters are directly associated with nosocomial UTI. This is compounded by antibiotic 
misuse resulting in a higher incidence of candida infections as well (20). Garraffo et al looked 
at how antibiotic exposure in the previous 12 months influenced resistance profiles with UTI. 
The study found a statistically significant relationship between antibiotic exposure and 
subsequent development of resistance: amoxicillin (71% vs 46%), first generation 
cephalosporins (65% vs 46%) and TMP/SMX (36% vs 15%) (18).  
 
Current guidelines for treating pyelonephritis recommend 7-10 days of appropriate, culture 
guided antibiotics. Children less than 3 months should be admitted for intravenous antibiotics 
whereas those over 3 months of age are adequately treated with an oral course (21). A three-
day course of antibiotics will suffice for an uncomplicated lower UTI. Longer course therapy 
has fewer treatment failures without a rise in reinfection (22). All children with first time UTI 
should have a screening ultrasound within 6 weeks to rule out anatomical anomalies (21). 
Children with recurrent infections, renal dysfunction, septicaemia or infection with non-E.coli 
organisms are recommended to have a dimercaptosuccinic acid scan within 4-6 months to 
rule out renal scarring (21). A micturating cystourethrogram (MCUG) may be done when 
vesicoureteric reflux (VUR) is suspected but is not recommended routinely (23). MCUG is 
costly, exposes the patient to considerable amounts of ionizing radiation and reflux correlates 
poorly with renal scarring (23). Contrast enhanced ultrasound is a more accurate alternative. 
 
Co-morbid Conditions:  
A study by Jeena et al retrospectively evaluated children admitted to King Edward VIII Hospital 
in Durban, South Africa between 1985-1992. UTI was the final diagnosis in only 4-17% of 
cases but, importantly, occurred frequently as part of other clinical presentations (24). UTI was 
found in 20-50% of acute diarrhoeal illness, 11-22% of acute respiratory illness and 23-44% 
of cases of protein energy malnutrition. Furthermore, only 13% of children had identifiable 
urinary tract signs (24). Kala et al also evaluated South African children with malnutrition and 
showed that UTI was present in 34.7% of cases (25). These finding concur with a similar study 
performed from in Turkey with UTI being prevalent in 30% of children (26). Human 
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Immunodeficiency Virus (HIV) is often associated with malnutrition in children. Asharam et al 
retrospectively evaluated 55 patients (29 children with HIV positive) admitted to King Edward 
Hospital in Durban, South Africa but failed to show an association with HIV and UTI. This can 
be attributed to the small sample size and therefore further investigation is warranted (27). 
  
Rationale for further investigation: 
South Africa is a developing country with a gross discrepancy between private and 
government medical resources. Understanding the microbial profile will help optimize these 
resources in the South African context and give insight into the burgeoning issues of resistant 
organisms in community infections. Furthermore, UTI often co-exists with other medical 
conditions. It is therefore important to assess these conditions and examine factors that 
influence positive urine cultures in patients presenting to emergency departments. 
Understanding the uropathogen profile in the South African context is of critical importance as 
this influences protocol implementation and antibiotic choice. Indiscriminate antibiotic usage 
has led to increased pressure on classes of antibiotic and, subsequently, an increase in 
pharmacotherapy resistance. The inherent public health burden requires that judicious 
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Chapter 2: The Microbial Burden and Antibiotic Profile of Paediatric Bacterial Urinary 




Paediatric urinary tract infection (UTI) is defined as the bacteriuria (bacterial growth of >105 
colony forming units/milliliter is regarded as the threshold) in the presence of signs and 
symptoms (1). The overall incidence of UTI’s in infants presenting with fever is 7% and 
accounts for 5-14% of visits to emergency departments annually (2). Uropathogenic 
Escherichia coli (E.coli) accounts for 60-70% of community acquired infections (1). Alberici et 
al reviewed the data found by the ESCAPE (Effect of Strict Blood Pressure Control and ACE 
Inhibition on the Progression of Chronic Renal Failure in Paediatric Patients) study group and 
showed that the uropathogen profile is evolving in both hospital and community settings.  E.coli 
caused <50% of UTI’s and Klebsiella spp, Enterococci with Proteus and Pseudomonas are 
emerging as community acquired uropathogens (3). 
 
Microbial resistance is a growing problem that requires standardized definitions and 
nomenclature. An international group of experts from the European Centre of Disease 
Prevention and Control (ECDC) and the Centre of Disease prevention and Control (CDC) 
came together to create standardized terminology to describe antimicrobial resistance. Multi-
drug resistance (MDR) is acquired resistance to at least one agent in three or more antibiotics 
categories. Extreme drug resistance (XDR) is acquired resistance to at least one agent in all 
but two or fewer antimicrobial categories (i.e. pathogens remain susceptible to at least two 
agents) (4). 
 
Calzi et al conducted a study in Genoa, Italy looking at resistance trends to oral antibiotics 
amongst gram negative rods from 2007 till 2014. Here, E. coli UTI had rates of resistance to 
co-amoxiclavulinic acid and ciprofloxacin of 23.6% and 6.5 % in 2007 and 35.6% and 9.4% in 
2011-2014 respectively (p<0.0001). Similar trends were seen amongst Enterobacteriaceae 
spp to trimethoprim/sulphamethoxazole (TMP/SMX) and ciprofloxacin with resistance rates of 
9,6% and 1.2% in 2007 and 18.1% and 6.1 % in 2011-2014 (p= 0.02 and p=0.0007) (5). Chen 
et al showed that E.coli extended spectrum beta-lactamase (ESBL) activity at a tertiary 
hospital in Taiwan was 2% in 2003 but increased to 11% in 2012; E.coli overall drug sensitivity 
was 20% to ampicillin, 61% to co-amoxiclavulinic acid, 85% to ceftriaxone, 68.7% to 
ceftazidime and 54.6% to cefotaxime (6). Another study conducted at 2 tertiary level hospitals 
in Northern Taiwan showed that cephalosporin prophylaxis increased rates of ESBL UTI 
(compared to TMP/SMX) and that antimicrobial susceptibility decreased to almost all antibiotic 
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classes. This was further aggravated by the use of repeated courses of different antibiotics 
(7). 
 
Maartens et al conducted a retrospective study looking at antimicrobial susceptibility in 
community acquired isolates causing UTI in adult females at Groote Schuur Hospital, Western 
cape South Africa in 1991. The overall antibiotic resistance in E.coli and Enterobacteriaceae 
isolates to amoxicillin, co-amoxiclavulinate and TMP/SMX was 65.1%, 18.7% and 47.3% 
respectively (8). A study conducted in Gauteng, South Africa in 2011 described the overall 
susceptibility of uropathogens, causing UTI in adult female patients, to TMP/SMX (44.3%), co-
amoxiclavulinic acid (82.8%), ciprofloxacin (94.1%) and nitrofuranotoin (91.7%) (9). 
 
Microbial resistance poses a challenge to South Africa’s health system. This problem is 
compounded by overuse and inappropriate prescription of antibiotics in the South African 
paediatric population. This study will evaluate the uropathogen population in paediatric (birth 
to 14 years) bacterial UTI and the respective antibiotic susceptibility profile and compare this 
to international data and trends. Furthermore, UTI will be classified into community, hospital 
associated and hospital acquired infections. These infections will then be linked to Human 




Urinary tract infection: Single organism growth >100 000cfu/ml and leukocytes >1000cells/ml 
in urine specimens sent to the laboratory 
Community Acquired Infection: Infection identified on presentation to the paediatric 
emergency unit in the absence of any prior admission in the preceding 30 days 
Hospital Associated Infection: Infection identified on presentation to the paediatric emergency 
unit with prior hospital admission in the preceding 30 days 
Hospital Acquired Infection: Infection after 72 hours post admission  
* Mono-drug resistance: Acquired resistance to 1 drug category 
* Multi-drug resistance: Acquired resistance to at least 1 agent in >3 antibiotic categories 
* Extreme drug resistance: Acquired resistance to >1 agent in all but <2 categories 
* Extended spectrum B-lactam producer: Organism resistant to 1st-3rd generation 
cephalosporin [class] antibiotics 
 
* Definitions taken from Magiorakas et al (4) 
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Materials and Methods 
 
Setting: 
This study was conducted at Tygerberg Hospital, a tertiaryl hospital in the Western Cape, 
South Africa; this hospital serves the Northern and Eastern rural districts of the Western Cape. 
The paediatric service comprises 309 beds providing neonatal, general and sub-specialist 
care. All urine cultures are performed on site at the medical microbiology laboratory of the 
National Health Laboratory Service (NHLS). 
 
Study Design: 
A retrospective descriptive analysis of all urine cultures, taken from patients aged birth-14 
years, from the NHLS databases between 1 January 2012 and 31 December 2013 was 
performed. This study was undertaken from 2015-2016. Samples included were those from 
children aged birth to 14 (completed) years with a positive pure [single] growth of a 
uropathogen. There were no interventions or diagnostic methods implemented for this study. 
 
Investigation of UTI: 
Urine samples were collected and sent to the laboratory based on clinical suspicion of UTI or 
if clinicians were investigating sources of pyrexia in paediatric patients. The methods of 
sample collection were often not recorded on the laboratory request form.  
 
The NHLS reports cell counts, presence of crystals and debris (if applicable) and the culture 
results of all urine specimens sent for analysis. Identification and microbial susceptibility is 
performed using the automated Vitek II platform and interpreted using annually published 
Clinical and Laboratory Standards Institute (CLSI) breakpoints.  
 
It should be noted that the NHLS at the study center did not release the uropathogens full 
antimicrobial sensitivity if the organism was sensitive to penicillin and cephalosporin 




The data provided by the NHLS was cross referenced with data on the electronic Clinicom 
Data Management system to stratify the specimens into community, hospital associated and 
hospital acquired infections by looking at the date of admission compared to the date when 
the sample was taken, as described previously. 
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Samples were further linked with concurrent blood culture and human immunodeficiency virus 
(HIV) tests/results. Voluntary counselling and testing for HIV is routinely offered to patients 
and parents. If the HIV status of patient was known during initial assessment, then formal HIV 
testing was not performed. HIV exposure and HIV results at the time of admission or from 




All data received from the laboratory was captured on electronic spread sheets. Data variables 
were allocated numerical codes and exported to statistical software (STATA v12; Statacorp) 
for further analysis. Complex analysis was done in partnership with the Department of 
Biostatistics at Stellenbosch University. Factors associated with positive culture was assessed 
bivariately using Pearson’s chi square test and Fisher’s test for categorical variables. 
Statistical significance was accepted if p<0.05. 
 
Ethics: 
The research Protocol “Paediatric Bacterial Urinary Tract Infections in the South African 
Context” (S14/09/182) was approved by the Human Research and Ethics Counsel (HREC) of 
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A total of 3616 samples from 1 January 2012 till 31 December 2013 were reviewed for 
inclusion. Forty-eight samples were from patients above 14 years old, 2350 urine samples 
had no growth, 924 samples were mixed growth/contaminated (i.e. multiple organisms were 
cultured) and 12 samples were submitted twice for the same patient during the index UTI. 282 
samples met the study definition and were included in the study. The median age for the group 
was 12.1 months (IQR: 2.9-42.3). These were further stratified into community UTI 
(170/60.3%), hospital associated UTI (52/18.4%) and hospital acquired UTI (60/21.3%) (figure 
1). 
 
Table 1 describes the overall and uropathogen specific demographic data of the samples 
included in the study. The mean age of the patients was 27.8 months with a male 
predominance (56.74%; p=0.004)). One hundred and forty-two (50.4%) samples were from 
patients below 1 year old; of whom, 90/63.4% were male. Of the culture confirmed UTI’s, 




Patients older than 14yrs (N=48) 
Urine cultures with No Growth 
(N=2350) 
Urine cultures with mixed 
growth/contaminated (N=924) 
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organism was E. coli (143/50.7%) followed by Klebsiella pneumoniae (64/22.7%), P. mirabilis 
(13 /4.6%) and Enterococcus species (13/4.6%).  
 
In 186 samples (65.9%) the patients did not have HIV serology results available. Only 
115/40.8% of the samples had a concurrent blood culture performed. Of those, 9 (3.2%) had 
a positive blood culture with their concurrent UTI. Of positive cultures, 77.8% were attributed 
to E. coli UTI complicated with a concurrent bacteraemia. 
 
A total of 75/26.6% cultured organisms were positive for ESBL production. Of those, 19/25.3% 
of samples were community acquired vs 24/32% which were hospital associated vs 32/42.7% 
which were nosocomial (p=0.0). E. coli displayed high level resistance to amoxicillin (90.8%), 
ampicillin (90.8%) and TMP/SMX (71.8%). K. pneumoniae showed high level resistance to the 
penicillin, penicillins with B-lactam antagonists, all cephalosporin’s categories, folate pathway 
inhibitors and nitrofurantoin (table 2). There was also marked resistance to gentamicin (76.6%) 
but was 74.5% sensitive to amikacin. Similar levels of resistance were seen in the 
Enterobacter spp group.  
 
Resistance amongst E. coli, K. pneumoniae and P. mirabilis infections were further described 
according to proposed definitions by the European Centre of Disease Prevention and Control 
(ECDC) and the Centre of Disease prevention and Control (CDC) (table 2 and 3) (4). K. 
pneumoniae was were more frequent with hospital associated and nosocomial infections 
(p=0.006). Although multi- and extremely drug resistant P. mirabilis (n=13) showed higher 
rates of resistance to penicillins and penicillins with Beta-lactams amongst males and in 
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Table 1: Total and Specific Uropathogen Demographic data 
 
E.coli	(n=143) K.	pneum	(n=64) P.	mirabilis	(n=13) Enterococ	spp	(n=13) Enterobact	spp	(n=6) Candida	spp	(n=20) Other	(n=22)
Gender	(n/%)
Male	 160/56.7% 69/43.1% 34/21.3% 9/5.6% 13/8.1% 4/2.5% 13/8.1% 18/11.3% p=0.004
Female	 122/43.3% 74/60.7% 30/24.6% 4/3.3% 1/0.8% 2/1.6% 7/5.7% 4/3.3%
Ward	(n/%)
General	 235/83.3% 136/95.1% 46/71.9% 11/84.6% 11/84.6% 4/66.7% 11/55% 16/72.7%
Neonatal	 27/9.6% 3/2.1% 13/30.3% 2/15.4% 2/15.4% 1/16.7% 2/10% 4/18.2%
ICU	 20/7.1% 4/2.8% 5/7.8% 0/0% 0/0% 1/16.7% 7/35% 2/9.1%
HIV	Status	(n/%)
Positive	 16/6.7% 3/18.8% 9/56.3% 0/0 2/12.5% 0/0 1/6.3% 1/6.3%
Negative	 80/28.4% 30/37,5% 24/30% 3/3,75% 2/2,5% 1/1,25% 13/16,25% 7/8,75%
Not	tested/done	 186/66% 110/59,14% 31/16,67% 10/5,38% 10/5,38% 5/2,69% 6/3,23% 14/7,53% p=0.0
Blood	Culture	(n/%) Sample	too	small
Positive	 9/3.2% 7/77.8% 0/0 0/0 0/0 0/0 0/0 2/22.2%
Negative	 91/32.3% 32/35.2% 32/35.2% 3/3,3% 7/7.7% 3/3.3% 9/9.9% 5/5.5%
Not	done	 167/59.2% 97/58.1% 28/16.8% 10/6% 7/4.2% 3/1.8% 8/4.8% 14/8.4%
Contaminated	 10/3.6% 5/50% 3/30% 0/0 0/0 0/0 1/10% 1/10%
Postive;	alternative	org	 5/1.8% 2/40% 1/20% 0/0 0/0 0/0 2/40% 0/0
Type	Infection	(n/%) Sample	too	small
Community	 170/60.3% 114/67.1% 17/10% 9/5.3% 8/4.7% 3/1.8% 8/4.7% 11/6.5%
Hosp	associated	 52/18.4% 20/38.5% 22/42.3% 0/0% 1/1.9% 1/1.9% 4/7.7% 4/7.7%
Nosocomial	 60/21.3% 9/15% 25/41.7% 4/6.7% 5/8.3% 2/3.3% 8/13.3% 7/11.7%









* Enterococcus spp includes Enterococcus faecalis (1/0.35%), Enterococcus faecium (1/0.35%) and Enterococcus species (13/4.61%) 
** Enterobacter spp includes Enterobacter aerogenes (3/1.06%) and Enterobacter cloacae (3/1.06%) 
*** Candida spp includes Candida albicans (16/5.67%) and Candida species (4/1.42%) 
**** Other includes Acinetobacter baumanii complex (1/0.35%), Acinetobacter baumanii (4/1.42%), Citrobacter freundi (1/0.35%), Hafnia alvei (2/0.71%), Klebsiella oxytoca (3/1.06%), Klebsiella 
pneumoniae spp ozaen (1/0.35%), Morganella morganii (3/1.06%), Pseudomonas auroginosa (2/0.71%), Raoultella planticola (1/0.35%), Serratia marcescens (2/0.71%), Serratia spp (1/0.35%), 
Staphylococcus aureus (2/0.71%)and Staphylococcus saprophyitcus (1/0.35%) 
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Table 2: In vitro Uropathogen Resistance to Tested Antibiotics 
 
Tested Resistance	(n/%) Tested Resistance	(n/%) Tested Resistance	(n/%) Tested Resistance	(n/%)
Penicillin Amoxicillin 142 129	(90.8) 64 64	(100) 13 11	(84.6) 4 4	(100)
Ampicillin	IV 142 129	(90.8) 64 64	(100) 13 11	(84.6) 4 4	(100)
Penicillin	(+	B	lactam	inhib) Co-amoxicillin 129 49	(38) 62 55	(88.7) 7 3	(42.9) 6 6	(100)
Piperacillin-tazobactam 15 9	(60) 38 28	(73.7) 2 2	(100) 2 2	(100)
1st/2nd	gen	Cephalosporin Cefuroxime	PO 138 26	(18.8) 64 55	(85.9) 13 0	(0) 5 5	(100)
Cefuroxime	IV 137 18	(13.1) 64 55	(85.9) 13 0	(0) 4 4	(100)
3rd/4th	gen	Cephalosporin Cefotaxime 52 15	(28.8) 55 54	(98.2) 3 0	(0) 3 3	(100)
Ceftriaxone 52 15	(28.8) 55 54	(98.2) 3 0	(0) 3 3	(100)
Ceftazidime 19 15	(78.9) 55 54	(98.2) 3 3	(100)
Cefepime 18 15	(83.3) 51 50	(98) 5 2	(40)
Cephamycins Cefoxatin 2 0	(0) 1 1	(100)
Aminoglycosides Gentamicin 141 18	(12.8) 64 49	(76.6) 13 3	(23.1) 6 3	(50)
Amikacin 22 4	(18.2) 51 13	(25.5) 3 0	(0) 3 1	(33.3)
Tobramycin 4 4	(100)
Fluoroquinolones Ciprofloxacin 52 11	(21.2) 48 23	(47.9) 7 1	(14.3) 4 2	(50)
Nalidixic	Acid 2 0	(0) 7 7	(100) 2 1	(50)
Carbapenems Imipenem 13 0	(0) 36 1	(2.8) 3 0	(0)
Ertapenem 14 0	(0) 47 0	(0) 4 0	(0)
Meropenem 16 0	(0) 41 0	(0) 3 0	(0)
Folate	pathway	inhib Trimethoprim-sulphamethoxazole	(cotrimox) 142 102	(71.8) 64 49	(76.6) 11 6	(54.5) 6 4	(66.7)
Nitrofuran	Derivatives Nitrofurantoin 6 1	(16.7) 14 12	(85.7) 5 5	(100) 2 2	(100)
Glycylcyclines Tigecycline 2 0	(0) 3 3	(100)










Table 3: Uropathogen Antibiotic Category Resistance 
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Sensitive Mono Dual MDR XDR Sensitive Mono Dual MDR XDR Sensitive Mono Dual MDR XDR
Gender:
Male	(n	=69) 3/4.4% 9/13.0% 25/36.2% 19/27.5% 13/18.8% p=0.542 0/0% 3/8.8% 2/5.9% 6/17.7% 23/67.7% p=0.726 1/11.1% 1/11.1% 3/33.3% 0/0% 4/44.4% p=0.225
Female	(n=74) 5/6.8% 12/16.2% 33/44.6% 13/17.6% 11/14.9% 0/0% 3/10% 0/0% 6/20% 21/70% 0/0% 0/0% 3/75% 1/25% 0/0%
Ward:
General	(n=136) 8/5.9% 19/14% 56/41.2% 31/22.8% 22/16.2% 0/0% 5/10.9% 2/4.4% 11/23.9% 28/60.9% 1/9.1% 1/9.1% 4/36.4% 1/9.1% 4/36.4%
Neonatal	(n=3) 0/0% 0/0% 1/33.3% 1/33.3% 1/33.3% 0/0% 0/0% 0/0% 1/7.7% 12/92.3% 0/0% 0/0% 2/100% 0/0% 0/0%
ICU	(n=4) 0/0% 2/50% 1/25% 0/0% 1/25% p=0.537 0/0% 1/20% 0/0% 0/0% 4/30% p=0.366 0/0% 0/0% 0/0% 0/0% 0/0% p=0.692
HIV	Status
Positive	(n=3) 0/0% 0/0% 1/33.3% 2/66.7% 0/0% 0/0% 0/0% 0/0% 1/11.1% 8/88.9% 0/0% 0/0% 0/0% 0/0% 0/0%
Negative	(n=30) 0/0% 2/6.7% 9/30% 12/40% 7/23.3% 0/0% 4/16.7% 0/0% 5/20.8% 15/62.5% 0/0% 1/33.3% 2/66.7% 0/0% 0/0%
Not	tested/done	(n=110) 8/7.3% 19/17.3% 48/43.6% 18/16.4% 17/15.5% p=0.037 0/0% 2/6.5% 2/6.5% 6/19.4% 21/67.7% p=0.674 1/10% 0/0% 4/40% 1/10% 4/40% p=0.241
Blood	Culture:
Positive	(n=7) 0/0% 2/28.6% 0/0% 4/57.1% 1/14.3% p=0.475 0/0% 0/0% 0/0% 0/0% 0/0% p=0.975 0/0% 0/0% 0/0% 0/0% 0/0% p=0.241
Negative	(n=32) 1/3.1% 4/12/5% 13/40.6% 8/25% 6/18.8% 0/0% 4/12.5% 1/3.1% 6/18.8% 21/65.6% 1/33.3% 0/0% 2/66.7% 0/0% 0/0%
Not	done	(n=97) 7/7.2% 14/14.4% 42/43.3% 18/18.6% 16/16.5% 0/0% 2/7.1% 1/3.6% 6/21.4% 19/67.9% 0/0% 1/10% 4/40% 1/10% 4/40%
Contaminated	(n=5) 0/0% 1/20% 1/20% 2/40% 1/20% 0/0% 0/0% 0/0% 0/0% 3/100% 0/0% 0/0% 0/0% 0/0% 0/0%
Postive;	alternative	org	(n=2) 0/0% 0/0% 2/100% 0/0% 0/0% 0/0% 0/0% 0/0% 0/0% 1/100% 0/0% 0/0% 0/0% 0/0% 0/0%
Type	Infection
Community	(n=114) 6/5.3% 19/16.7% 48/42.1% 25/21.9% 16/14.% 0/0% 5/29.4% 2/11.8% 3/17.7% 7/41.2% 1/11.1% 1/11.1% 3/33.3% 1/11.1% 3/33.3%
Hosp	associated	(n=20) 2/10% 2/10% 8/40% 4/20% 4/20% 0/0% 1/4.6% 0/0% 5/22.7% 16/72.7% 0/0% 0/0% 0/0% 0/0% 0/0%
Nosocomial	(n=9) 0/0% 0/0% 2/22.2% 3/33.3% 4/44.4% p=0.380 0/0% 0/0% 0/0% 4/16% 21/84% p=0.006 0/0% 0/0% 3/75% 0/0% 1/25% p=0.656
E.	coli	(n=143) K.	pneumoniae	(n=64) P.	mirabilis	(n=13)
 
Monodrug resistance (Mono): Acquired resistance to 1 drug category 
Multi-drug resistance (MDR): Acquired resistance to at least 1 agent in >3 antibiotic categories 
Extreme drug resistance (XDR): Acquired resistance to >1 agent in all but <2 categories 
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The majority of urine samples sent to the NHLS were sterile and did not culture a uropathogen 
(n=2350). Of samples considered a UTI in this study, 170/60.3% were community derived, 
52/18.4% hospital associated and 60/21.3% hospital acquired infections. The median age for 
the group was 12.1 months (IQR: 2.9-42.3); data reports that patients younger than 5 years 
old are at higher risk of UTI (10). Gram negative enteric bacteria predominated in line with 
international data. E. coli remains the dominant organism (50.7%) in this study followed by K. 
pneumoniae, P. mirabillis and Enterococcus spp. Rates of E. coli infection causing UTI have 
been reported to be between 60% - 80.3% and 7% - 26% for K. pneumoniae (1,5,11–13). The 
lower rates of E. coli infection demonstrate a loss of supremacy and emergence of newer 
organisms possibly due to drug selection pressure. Further reasons for this are not 
immediately apparent. 
 
E. coli and K. pneumoniae accounted for 69/92% of total ESBL infections. Of ESBL infections, 
19/25.3% were attributed to community acquired infections. The rates of hospital acquired 
ESBL infection from a tertiary hospital in Pretoria, South Africa for E. coli and K. pneumoniae 
are 11.9% and 40.6% respectively (14). Rates of E. coli ESBL infections range from 11% - 
39.4% (6,12). 
 
Hospital acquired ESBL UTI represented 42.7% of total ESBL infections (p=0.0); E. coli 
represented 20% and K. pneumoniae 72%% of ESBL UTI in this study (p=0.0). Dramowski et 
al reported that Klebsiella spp accounted for 16% of community acquired and  51% of hospital 
acquired bacteraemias. E (15). This reflects an increase in Klebsiella spp infection in our 
environment. There is a global increase in both community and hospital acquired ESBL UTI 
infections. Dayan et al showed that community ESBL infection increased from 1% in 2007 to 
5.8% in 2012 in Israel (16). A retrospective study in Thailand found the prevalence of 
community ESBL producing organisms to be 19.2% (95% CI: 13.8-25.7) (17). Factors 
implicated in exacerbating community ESBL infections were previous hospital admissions, 
previous use of penicillins or fluroquinolones, recurrent UTI and genitourinary tract anomalies 
(18). We did not assess risk factors for community acquired ESBL infection due to the 
retrospective nature of this study. 
 
The pooled prevalence of ESBL Enterobacteriaceae is 14% (95% CI: 8-21), however the 
actual incidence may be as high as 40% in Europe; vesico-ureteric reflux (OR 2.79), history 
of UTI (OR 2.89) and recent antibiotic use (OR 2.92) were risk factors identified (19).  
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Of ESBL E. coli UTI in this study, 1/6.7% and 5/33.3% was sensitive to piperacillin-tazobactam 
and amikacin respectively. ESBL K. pneumoniae displayed 10/18.5% and 37/68.5% sensitivity 
to piperacillin-tazobactam and amikacin respectively. These antibiograms support current 
hospital policy to treat hospital associated and acquired infections with piperacillin-tazobactam 
and amikacin until urine culture and sensitivity are available, thereby limiting carbapenem drug 
pressure. 
 
Table 4 displays E. coli resistance rates from this study compared to data from a European 
multicenter study, data from Taiwan and two studies performed in India (3,6,20,21). The 
antibiotics listed are those commonly used at primary and secondary level health services.  
 
Study Site Amoxicillin Co-amoxicillin TMP/SMX Cefotaxime Ceftriaxone Ciprofloxacin Amikacin Piptaz
Index	Study South	Africa 90.8% 38% 71.8% 28.8% 28.8% 21.2% 18.2% 9%
Alberici	et	al European	Multicentre >50% 20-50% >50% 0-50%
Chen	et	al Taiwan 80% 39% 53% 55.4% 15%
Rajiv	et	al India 98% 88% 73.5% 73.5% 63.3% 21.4%
Mishra	et	al india 39% 36% 31% 36% 31% 38%
E.	coli	Drug	Resistance
 
Table 4: E. coli Resistance Rates from Index study Compared to International Data 
 
Cheng et al further described decreasing sensitivity rates for K pneumoniae and Proteus spp 
to cefazolin; sensitivity was 72% and 60% in 2008 and 44% and 10% in 2012 respectively (6). 
The author found that K. pneumoniae exhibited 85.9% resistance to first and second 
generation cephalosporins and >98% resistance to third and fourth generation 
cephalosporins. This is of relevance as 64/22.7% of UTI’s were attributed to K. pneumoniae; 
17/26.5% of which are community and 22/34.4% hospital associated UTI. P. mirabillis showed 
100% sensitivity to all cephalosporins tested by the NHLS. 
 
Blood for cultures are only drawn if the treating physician deems them clinically indicated; 9 
(3.2%) patients with UTI had a positive blood culture but 167 (59.2%) had no culture sample 
drawn. There was no statistically significant correlation with causative organisms and antibiotic 
resistance against patients with positive blood cultures. Megged et al showed that male 
gender, age <3 months, higher creatinine and underlying urological abnormalities were 
significant risk factors for the development of bacteraemia (22). A retrospective study 
conducted at the same study site looking at blood stream infections in paediatric patients from 
January 2008 till December 2013 reported a 5.5% pathogen yield from all blood cultures drawn 
(23). 
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Further investigation is warranted to look at the true influence of HIV infection and risk of UTI 
as the numbers were too small in the present study. Asharam et al showed no significant 
impact of HIV/AIDS on antibiotic sensitivity, response to therapy or duration of hospitalization 
(24).   
 
Our study provides an insight into the changing UTI organism population as well as antibiotic 
resistance/susceptibility profile. Antibiotic resistance is a developing challenge that requires 
use of judicious use of antimicrobial therapy. Future studies would be required to further 
explore resistance profiles as to better guide clinician’s antibiotic prescription practices.  
 
The major limitation to this study was that we were unable to assess for risk factors 
predisposing to UTI organism resistance. This included recent hospital exposure/admission 




The results evidenced in this study show that the organism profile of paediatric UTI is changing 
in line with international data trends. K. pneumoniae underlies 10% of culture positive 
infections. ESBL producing organisms were noted in 75 (64.1%) of UTI, of which K. 
pneumoniae accounted for 54. Furthermore, 25.3% of ESBL producers arise from the 
community setting. Extremely drug resistant K. pneumoniae species were significantly more 
likely to originate from hospital acquired infections. Health care practitioners should 
demonstrate judicious antibiotic practices to curb growing resistance by prescribing 
appropriate antibiotics and rationalize therapy based on urine microscopy culture and 
sensitivity results. 
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Chapter 3: Factors Impacting Positive Urinary Tract Infections in patients (0-5 years) 
Attending a Paediatric Emergency ward in a Tertiary Care Hospital in the Western 




Paediatric urinary tract infection (UTI) is defined as the presence of organisms in the urine 
with > 105 colony forming units/milliliter (cfu/ml) considered significant. UTI accounts for 5-
14% of emergency department visits annually (1). The pooled prevalence rates of febrile UTI 
in female infants aged 0-3, 3-6 and 6-12 months was 7.5%, 5.7% and 8.3% respectively and 
remains more common amongst pre-school children compared to school age children with 
rates of 1-3% and 0.7-2.3% respectively (2). Risk factors for UTI in the febrile infant are age, 
gender, circumcision status in boys, race and duration of fever (3). 
 
The most common bacterial pathogens are gram negative enteric organisms such as 
Escherichia coli (E. coli) and Klebsiella species; virulence factors (adhesins and haemolysins) 
allow these organisms to damage the uroepithelium (4). Adenovirus and Candida infection 
has also been implicated in causing haemorrhagic cystitis (5). Urine culture is the gold 
standard for diagnosis as signs and symptoms in the younger patient can often be non-specific 
(6).  
 
Pyelonephritis can lead to significant morbidity. Shaikh et al, in a systematic review, reported 
that of children presenting with a first UTI, 57% (95% CI: 50-64) had changes consistent with 
acute pyelonephritis on the acute phase dimercaptosuccinic acid (DMSA) scan renal scan. 
On follow up scan, and 15% (95% CI: 11-18) had evidence of renal scarring on the follow up 
scan (7). UTI is the first presentation in 30% of children urinary tract anomalies (8). This 
includes vesico-ureteric reflux and obstructive uropathies predispose patients to 
pyelonephritis (9). The American Academy of Paediatrics recommends that patients 
diagnosed with a UTI, receive 7-14 days of antibiotics, and are monitored for recurrent 
infections and an ultrasound evaluation of the renal tract to rule out structural anomalies (3). 
However, these recommendations are quality B evidence for antibiotic use quality C evidence 
for imaging studies. UTI may progress and result in complications that include renal 
abscesses, septicaemia, renal scarring, hypertension and chronic kidney disease (10). 
 
This study evaluated factors that influence positive urine cultures in patients from birth till 5 
years at Tygerberg Hospital paediatric emergency room and to describe the correlation with 
urine dipsticks, serum inflammatory marker and renal imaging studies. Factors considered are 
clinical signs, antibiotic exposure and spectrum of co-morbid conditions.  
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Materials and Methods 
 
Setting: 
The study was conducted at Tygerberg Hospital, a tertiary level hospital in the Western Cape, 
South Africa. The paediatric emergency room protocols dictate that patients younger that 3 
months old, patients with suspected bacteraemia or those with pyrexia of unknown origin have 
urine dipsticks +/- formal laboratory based urine analysis when screening for potential sites of 
sepsis. At the time of the study, urine dipsticks +/- formal analysis was done at the discretion 
of the attending clinician in patients older than 3 months of age. All urine cultures are 
performed on site at the medical microbiology laboratory of the National Health Laboratory 
Service (NHLS). 
 
Study Design and Data Management: 
 
A convenience sample children (birth-5 years) presenting to the emergency unit, in whom 
urine samples were submitted, were prospectively enrolled into the study provided informed 
individual consent was obtained from the parent/guardian. Patients were further subdivided 
into those below or above 3 months of age. The casualty protocols at the study site dictate 
that patients younger than 3 months have urine dipsticks +/- laboratory based urine analysis 
when screening patients for potential sites of sepsis. Patients that presented to the hospital 
on multiple occasions were eligible for re-recruitment into the study. Data was collected using 
preformed collections sheets. Patients were randomly allocated predetermined study numbers 
to ensure anonymity and confidentiality. These numbers were used to link patients to the 
electronic sheet. Data sources further included patient files/records, NHLS and radiology 
electronic databases and Clinicom and ECM electronic patient information. 
 
We defined UTI as culture of a single organism from a urine sample sent to the NHLS. Mixed 
growth on urine samples were treated as contaminates by the attending doctors; these 
samples were not repeated. Nutritional definitions were according to the World Health 












In consultation with the Department of Biostatistics, a power analysis showed that a sample 
size of 100 patients would be adequate for statistical significance to correlate co-morbidities 
with UTI. The characteristics of the patients were described using standard descriptive 
analysis. Data analysis was performed using Stata version 12 (StataCorp). Factors associated 
with positive culture were assessed bivariately using Pearson’s chi square test for categorical 
variables and t-tests for continuous variables. Binary logistic regression analysis was used to 
adjust the estimates for confounding.  
 
Ethics: 
The research Protocol “Paediatric Bacterial Urinary Tract Infections in the South African 
Context” (S14/09/182) was approved by the Human Research and Ethics Counsel (HREC) of 




























A total of 126 patients were screened and prospectively enrolled from the paediatric 
emergency unit at Tygerberg Hospital from February – June 2015. Informed individual consent 
was obtained for all patients. No parent refused participation. Three patients were excluded 
as their respective urine samples were not received by the NHLS (figure 1).  
 


















The median age was 83 days (IQR: 29-320); 59/48% were from males. Sixty-five (52.8%) 
were submitted from children < 3 months old (Figure 1 and Table 1). Patients < 3 months old 
had median age 32 days (IQR 21-50) and those > 3 months had a median age 345.5 days 
(IQR 182-468). 
 
Twenty-nine (23.6%) of those patients had culture confirmed UTI, 34 (27.6%) had mixed 
organism growth on urine culture; 21 (61.8%) of those samples were sourced from infants < 
3 months old. Thirty-eight (58.5%) patients with UTI younger than 3 months old were male 




3 Patients excluded: 
no urine sample 
received at NHLS 
123 Patients 
eligible for study 
participation and 
analysis 
58 (47.2%) Patients 
> 3 months old 
65 (52.8%) 
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(37/63.8%); there was no statistical significance in gender in these sub groups (p=0.08 and 
p=0.776 respectively).  
 
The indications for sending urine samples for culture varied and included investigation for 
suspected source of bacteraemia in 63 (51.2%) children, suspected UTI in 34 (27.6%) and 
acute gastroenteritis in 10 (8.1%). Specimens were obtained via sterile in and out catheter in 
101 (82.1%) children and 9 (7.3%) samples were collected via perineal bag collection. 
The most common co-morbidity was acute gastro-enteritis; 46 (37.4%) patients presented with 
diarrhoeal disease but this was not predictive for the confirmed UTI (p=0.344). Forty-five 
(36.6%) of patients were assessed as having possible occult bacteraemia. Twenty-five 
(20.3%) children had a lower respiratory tract infection; these patients were less likely to have 
concurrent UTI (OR 0.23 95% CI: 0.05-1.04; p=0.056). This was also demonstrated amongst 
patients younger than 3 months (OR 0.09 95%CI: 0.01-1.63; p=0.103). 
 
E. coli was isolated in 12 (41.4%) followed by Klebsiella pneumoniae in 9 (31%) cases. Three 
E. coli and 4 K. pneumoniae samples were extended spectrum beta lactamase (ESBL) 
producers. Other organisms identified included Candida albicans 4 (13.8%), non-Candida 
albicans species 1 (3.4%), S. marcescens 1 (3.4%), E. faecalis 1 (3.4%) and Acinetobacter 
baumanii 1 (3.4%). Of the fungal UTI’s, 3 (60%) patients had > 50 000 cells/mm2 and 3 (60%) 
had severe acute malnutrition.  
 
E. coli was 100% resistant to amoxicillin, 66.7% to cefuroxime, 25% to ceftriaxone/cefotaxime 
and 75% and 66,7% resistant to trimethoprim/sulphamethoxazole (TMP/SMX). K. 
pneumoniae showed 100% resistance to amoxicillin, 44.4% resistance to cefuroxime and 
ceftriaxone/cefotaxime and 66.7%. E. coli and K. pneumoniae sensitivity to co-amoxiclavulinic 
acid and ciprofloxacin was 25% and 91.7% and 44.4% and 100% respectively. ESBL E. coli 
was 33.3% and 66.7% resistant to ciprofloxacin and amikacin respectively. ESBL K. 
pneumoniae was 100% sensitive to these drugs. 
 
Of the samples with mixed growth on urine culture, 8 were positive for leukocyte esterase (on 
urine dipsticks), 1 was positive for nitrates and 1 sample had both leukocyte esterase and 
nitrate. None of these samples had repeated urine samples sent for culture.  
 
Eighteen (14.6%) patients had severe acute malnutrition but this was not statistically 
significant for predicting confirmed UTI (p=0.391); 2 (11.1%) had a positive urine culture. 
There was no difference in the ratio of malnutrition in children < 3 and those > 3 months old. 
Patient’s > 3 months old were less likely to have a concurrent UTI (p=0.023).  
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Twenty-six children (21.1%) were HIV exposed. Of those, 10 (47.6%) patients had culture 
confirmed UTI; 1 (10%) was HIV positive, 7 (70%) was HIV negative and 2 (20%) patients’ 
HIV status was not yet tested. Patients who were HIV exposed from the total patient population 
(OR 2.57 95% CI: 1.01-6.54; p=0.048) and those > 3 months old (OR 4.45 95% CI: 1.17-
16.89; p=0.028) were less likely to have a UTI. The patient’s HIV status did not influence the 
development of UTI; only 3 patients (2.4%) in the study were HIV positive. A total of 69 (56.1%) 
patients did not have HIV status documented. 
 
Table 2 illustrates the relationship between signs and symptoms, co-morbidities and previous 
antibiotic exposure on the development of UTI. Sixty-one (49.6%) patients presented with 
fever (either on history or documented pyrexia >37.5 oC) and 77 (62.6%) had irritability as 
presenting complaint. Duration of pyrexia was not documented. The major sign that attending 
clinicians found on initial assessment was suprapubic pain. There was no statistically 
significant correlation between signs and symptoms and culture confirmed UTI.  
 
Thirty-three (26.8%) caregivers reported their children receiving antibiotics in the previous 
year,  of whom, 21 received amoxicillin. Nine parental caregivers were not sure what type of 
antibiotic was prescribed; it was not documented in the Road to Health Card either). Forty-two  
(34.1%) childrenreceived intramuscular ceftriaxone according to the integrated childhood 
management of illness (IMCI) algorithms; patients were less likely to have confirmed UTI but 
this was not statistically significant (OR 0.47 95% CI: 0.14-1.57; p=0.22). Twenty-eight (22.8%) 
children had received antibiotics in the casualty at the study site prior to the urine sample 
being sent to the laboratory.  
 
Urine dipstick positive for nitrates (p=0.043) and leukocytes (0.018) correlated with positive 
urine culture (table 3). This was not statistically significant in patients less than 3 months old; 
only 46 (70.8%) patients had urine dipstick analysis prior to a urine sample being sent to the 
laboratory.  
 
C-reactive protein (CRP) was drawn on 38 patients from the study population at presentation. 
The mean CRP in patients with confirmed UTI (n=7) was 67.4 (IQR: 19.6-95.1) and was 37.6 
(IQR: 12.5-48.8) in those without UTI (n=31) (p=0.19). Two patients had confirmed concurrent 
bacteraemia with UTI. Kidney, ureter and bladder (KUB) ultrasound was likely to be normal in 
patients with UTI for the total sample and subdivided population (p= 0.0). 
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Table1: Demographic data of the Study Population 
 
Total	(n=123) UTI	(n=29) No	UTI	(n=94) Total	(n=65) UTI	(n=11) No	UTI	(n=54) Total	(n=58) UTI	(n=18) No	UTI	(n=40)
Age,	days:	median	(IQR) 83	(29-320) 125	(49-364) 66	(27-310) 32	(21-50) 42	(21-55) 31	(21-50) 345.5	(182-468) 293.5	(170-421) 357.5	(185-554)
Gender	(n/%)
Male	 59	(48) 16	(27.1) 43	(72.9) p=0.374 38	(58.5) 9	(23.7) 29	(76.3) p=0.08 21	(36.2) 7	(33.3) 14	(66.7) p=0.776
Female	 64	(52) 13	(20.3) 51	(79.7) 27	(41.5) 2	(7.4) 25	(92.6) 37	(63.8) 11	(29.7) 26	(70.3)
Nutrition:	weight	(n/%)
Severe	 21	(17.1) 4	(19) 17	(81) p=0.471 6	(9.2) 1	(16.7) 5	(83.3) p=0.813 15	(25.9) 3	(20) 12	(80) p=0.42
Moderate 15	(12.2) 2	(13.3) 13	(86.7) 10	(15.4) 1	(10) 9	(90) 5	(8.6) 1	(20) 4	(80)
Normal 87	(70.1) 23	(26.4) 64	(73.6) 49	(75.4) 9	(18.4) 40	(81.6) 38	(65.5) 14	(36.8) 24	(63.2)
Nutrition:	height	(n/%)
Severe	 18	(14.6) 2	(11.1) 16	(88.9) p=0.391 7	(10.8) 2	(28.6) 5	(71.4) p=0.346 11	(19) 0	(0) 11	(100) p=0.038
Moderate	 13	(10.6) 3	(23.1) 10	(76.9) 7	(10.8) 0	(0) 7	(100) 6	(10.3) 3	(30) 3	(50)
Normal	 92	(74.8) 24	(26.1) 68	(73.9) 51	(78.4) 9	(17.7) 42	(82.3) 41	(70.7) 15	(36.6) 26	(63.4)
Nutrition:	length/height	(n/%)
Severe	 18	(14.6) 2	(11.1) 16	(88.9) p=0.391 7	(10.8) 2	(28.6) 5	(71.4) p=0.346 11	(19) 0	(0) 11	(27.5) p=0.023
Moderate	 13	(10.6 3	(23.1) 10	(76.9) 7	(10.8) 0	(0) 7	(100) 6	(10.3) 3	(16.7) 3	(7.5)
Normal	 92	(74.8) 24	(26.1) 68	(73.9) 51	(78.5) 9	(17.7) 42	(82.4) 41	(70.7) 15	(36.6) 26	(63.4)
HIV	Exposure	(n/%)
Exposed	 26	(21.1) 10	(38.5) 16	(61.5) p=0.044 14	(21.5) 3	(21.4) 11	(78.6) p=0.438 12	(20.7) 7	(58.3) 5	(41.7) p=0.022
Not	exposed	 97	(78.9) 19	(19.6) 78	(80.4) 51	(78.5) 8	(15.7) 43	(84.3) 46	(79.3) 11	(23.9) 35	(76.1)
HIV	Status	(n/%)
Test	not	done	 69	(56.1) 13	(18.8) 56	(81.2) p=0.448 38	(58.5) 4	(10.5) 34	(89.5) p=0.206 31	(53.5) 9	(29) 22	(71) p=0.825
Positive	 3	(2.4) 1	(33.3) 2	(66.7) 1	(1.5) 0	(0) 1	(100) 2	(3.5) 1	(50) 1	(50)
Negative	 50	(40.7) 15	(30.0) 35	(70) 26	(40) 7	(26.9) 19	(73.1) 24	(41.4) 8	(33.3) 16	(66.7)




Table 2: Variables (history, co-morbidities and antibiotic exposure) and the influence on UTI in Paediatric Patients 
Stellenbosch University  https://scholar.sun.ac.za
Stellenbosch University  https://scholar.sun.ac.za
29 
 
Total	(n=123) UTI	(n=29) No	UTI	(n=94) Total	(n=65) UTI	(n=11) No	UTI	(n=54) Total	(n=58) UTI	(n=18) No	UTI	(n=40)
Presenting	Signs	&	Symptoms	(n/%)
Fever	 61	(49.6) 13	(21.3) 48	(78.7) p=0.557 28	(43.1) 4	(14.3) 24	(85.7) p=0.622 33	(56.9) 9	(27.3) 24	(72.7) p=0.477
Dysuria	 13	(10.6) 5	(38.5) 8	(61.5) p=0.181 1	(1.5) 0	(0) 1	(100) p=0.649 12	(20.7) 5	(41.7) 7	(58.3) p=0.371
Irritabilty	 77	(62.6) 19	(24.7) 58	(75.3) p=0.710 37	(56.9) 7	(18.9) 30	(81.1) p=0.622 40	(69) 12	(30) 28	(70) p=0.8
Vomiting	 47	(38.2) 15	(31.9) 32	(68.1) p=0.087 16	(24.6) 2	(12.5) 14	(87.5) p=0.587 31	(53.5) 13	(42) 18	(58) p=0.5
Loss	of	appetite	 43	(35) 11	(25,6) 32	(74.4) p=0.701 15	(23.1) 2	(13.3) 13	(86.7) p=0.672 28	(48.3) 9	(32.1) 19	(67.9) p=0.86
Suprapubic	Pain	 7	(4.9) 3	(42.9) 4	(57.1) p=0.354 7	(12.1) 3	(42.9) 4	(57.1) p=0.471
Renal	Angle	Pain	 1	(0.8) 0	(0) 1	(100) p=0.577 1	(1.7) 0	(0) 1	(100) p=0.499
Comorbidities	(n/%)
Malnutrition	(SAM) 29	(23.6) 5	(17.2) 24	(82.8) p=0.323 16	(24.6) 2	(12.5) 14	(87.5) p=0.195 13	(22.4) 3	(23.1) 10	(76.9) p=0.877
LRTI 25	(20.3) 2	(8) 23	(92) p=0.04 16	(24.6) 2	(12.5) 14	(87.5) p=0.587 9	(15.5) 0	(0) 9	(100) p=0.029
Gastroenteritis 46	(37.4) 13	(28.3) 33	(71.7) p=0.344 20	(30.1) 6	(30) 14	(70) p=0.061 26	(44.8) 7	(26.9) 19	(73.1) p=0.542
Suspected	Bacteraemia 45	(36.6) 10	(22.2) 35	(77.8) p=0.788 39	(60) 8	(20.5) 31	(79.5) p=0.344 6	(10.3) 2	(33.3) 4	(66.7) p=0.898
Other 19	(15.5) 4	(21.1) 15	(78.9) p	=	0.778 6	(9,2) 1	(16.7) 5	(83.3) p	=0.986 13	(22.4) 3	(23.1) 10	(76.9) p=0.481
Antibiotic	Exposure	(n/%)
In	Previous	year	 33	(26.8) 11	(33.3) 22	(66.7) p=0.123 8	(12.3) 2	(25) 6	(75) p=0.515 25	(43.1) 9	(36) 16	(64) p=0.477
IMCI	Antibiotics 42	(34.1) 6	(14.3) 36	(85.7) p=0.08 19	(29.2) 1	(5.3) 18	(94.7) p=0.107 23	(39.7) 5	(21.7) 18	(78.3) p=0.215
Antibiotic	before	sample	 28	(22.8) 4	(14.3) 24	(85.7) p=0.188 16	(24.6) 1	(6.3) 15	(93.7) 12	(20.7) 3	(25) 9	(75) p=0.612
Total	(n=123) <	3	months	old	(n=65) >	3	months	old	(n=58)
 
SAM: severe acute malnutrition 
LRTI: Lower Respiratory Tract Infection 
Other co-morbidities include post-infectious glomerulonephritis (n=1), seizures (n=7), pelviureteric junction obstruction (n=1), VACTERL association (n=1), constipation (n=1), 
renal failure (n=1), distended abdomen (n=1), patent ductus arteriosus with cardiac failure (n=1), cardiomyopathy (n=1), not documented (n=4) 
IMCI: integrated management of childhood illness 
 
 
Table 3: Investigations and the Correlation with Culture Positive UTI 
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Total	(n=123) UTI	(n=29) No	UTI	(n=94) Total	(n=65) UTI	(n=11) No	UTI	(n=54) Total	(n=58) UTI	(n=18) No	UTI	(n=40)
Dip:	NAD	(%) 24	(24.2) 5	(20.8) 19	(79.2) p=0.567 17	(37) 3	(17.7) 14	(82.4) p=0,634 7	(13.2) 2	(28.6) 5	(71.4) p=0,831
Dip:	Leukocytes	(%) 36	(36.4) 14	(38.9) 22	(61.1) p=0.018 16	(34.8) 4	(25) 12	(75) p=0,32 20	(37.7) 10	(50) 10	(50) p=0,03
Dip:	Nitrates	(%) 9	(9.1) 5	(55.6) 4	(44.4) p=0.043 0	(0) 0	(0) 0	(0) 9	(17) 5	(55.6) 4	(44.4) p=0,126
Dip:	Other	(%) 56	(56.6) 12	(21.4) 44	(78.6) p=0.608 19	(29.2) 2	(10.5) 17	(89.5) p=0,377 37	(63.8) 10	(27) 27	(73) p=0,381
Blood	culture	(n/%)
Test	not	done	 22	(17.9) 6	(27.3) 16	(72.7) 4	(6.2) 0	(0) 4	(100) 18	(31) 6	(33.3) 12	(66.7)
Positive	 8	(6.5) 2	(25) 6	(75) 1	(1.5) 0	(0) 1	(100) 7	(12.1) 2	(28.6) 5	(71.4)
Negative	 91	(74) 20	(22) 71	(78) p=0.623 58	(89.2) 10	(17.2) 48	(82.8) p=0,461 33	(56.9) 10	(30.3) 23	(69.7) p=0,964
Contaminant	 2	(1.6) 1	(50) 1	(50) 2	(3.1) 1	(50) 1	(50) 0	(0) 0	(0) 0	(0)
KUB	US	(n=123/%)
Normal	 25	(20.3) 17	(68) 8	(32) p=0.0 12	(18.5) 7	(58.3) 5	(41.7) p=0.0 13	(22.4) 10	(76.9) 3	(23.1) p=0.0
Abnormal	 7	(5.7) 1	(14,3) 6	(85,7) 2	(3.1) 0	(0) 2	(100) 5	(8.6) 1	(20) 4	(80)
Not	applicable	 74	(60.2) 0	(0) 74	(100) 45	(69.2) 0	(0) 45	(100) 29	(50) 0	(0) 29	(100)
Not	Done	 17	(13.8) 11	(64,7) 6	(35,3) 6	(9.2) 4	(66.7) 2	(33.3) 11	(19) 7	(63.6) 4	(36.4)
Lost	to	follow	up	(n/%)
Yes	 18	(14.6) 11	(61,1) 7	(38,9) p=0.0 6	(9.2) 4	(66.7) 2	(33.3) p=0.01 12	(20.7) 7	(58.3) 5	(41.7) p=0.067
No		 5	(4.1) 1	(20) 4	(80) 2	(3.1) 0	(0) 2	(100) 3	(5.2) 1	(33.3) 2	(66.7)






Dip: [Urine] dipstick 
NAD: No Abnormality Detected  
KUB: Kidney, Ureter and Bladder Ultrasound
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Paediatric UTI is an important diagnosis to be considered in the febrile patient presenting to 
the accident and emergency unit. The current paediatric emergency room protocols dictate 
that patients younger that 3 months old, patients with suspected bacteraemia or those with 
pyrexia of unknown origin have urine dipsticks +/- formal laboratory based urine analysis when 
screening patients for potential sites of sepsis. Urine dipsticks +/- microscopy is done at the 
discretion of the attending clinician in patients above 3 months of age. In this study, 29 (23.6%) 
patients had culture confirmed UTI. A study done in Ghana on 1393 children <5 years old who 
had screening urine dipsticks positive for leukocyte esterase and/or urinary nitrates had a 8% 
positive urine culture with an identified uropathogen (12). This disparity in culture positive rates 
requires further study and revision of current urine screening protocols at the study site.    
 
The organism profile found in this study is in line with international studies and shows that K. 
pneumoniae is emerging as a significant community acquired pathogen (13,14). This finding 
is also supported by data presented in the retrospective study (chapter 2) performed by the 
author. Furthermore, community acquired ESBL infection and drug resistance mirrors 
international trends (15,16) in this study. Factors predisposing to ESBL infection are recent 
hospitalization, previous UTI, urinary tract anomalies and antimicrobial prophylaxis 
(14,15,17,18). This should be considered in guiding appropriate antibiotic choice in patients 
with suspected UTI. Viral pathogens (adeno-, cytomegalo- and BK virus) have been implicated 
in causing urinary tract infection in immunocompromised patients (19). A prospective study 
conducted in Poland followed 102 children undergoing bone marrow transplantation; 25.5% 
developed haemorrhgic cystitis with BK virus being detected in 80.8% of those samples (20). 
The present study did not evaluate viral UTI. 
 
Patients who were HIV exposed were more likely to develop UTI however these patiets are 
over represented in the South African setting. Leukocyte esterase and nitrates on urine 
dipsticks correlated with confirmed UTI. Patients with severe acute malnutrition (weight for 
height/length <3SD) and having a lower respiratory tract infection (OR=0.23) were less likely 
to develop a concurrent UTI. However, only 18 (14.6%) of patient had severe acute 
malnutrition as per WHO definitions. Patient’s with UTI were more likely to have a normal renal 
ultrasound. 
 
Paediatric UTI is difficult to diagnose thus making rapid reagent urinary dipsticks an effective 
tool to assist the clinician. Zorc et al conducted a meta-analysis of various diagnostic 
modalities. Leukocyte esterase has a sensitivity of 83% and specificity of 84%. Nitrates are 
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not very sensitive (50%) but highly specific 98% (5), supported by the data is in this study. 
Fitzgerald et al conducted a study at a children’s hospital in Dublin using point of care urine 
microscopy as an adjunct in the diagnosis of UTI. The study team showed a 0.64 correlation 
between emergency unit and laboratory based diagnosis of UTI (21). This might be a viable 
option to assist in rapid diagnosis of UTI and earlier initiation of appropriate therapy. 
 
There was no statistically significant correlation between UTI and concurrent bacteraemia. 
However, it should be noted that 2 (1.6%) patients had a parallel bacteraemia. Megged at al 
reported that male gender, age <3 months, higher creatinine and underlying urological 
abnormalities risk factors for UTI with bacteraemia (22). 
 
Asharam conducted a retrospective study on children with HIV infection and UTI co-infection 
and evaluated clinical presentation, duration of hospitalization, aetiology, antimicrobial 
susceptibility and renal function. HIV disease had no significant impact on the presentation of 
UTI (23). Our study showed that HIV exposure was statistically significant for developing 
culture proven UTI (p=0,044) but HIV infection did not affect concurrent UTI; 8 (2.4%) patients 
had HIV disease. As of 2015, it is estimated that  7 millions South Africans are living with HIV 
and that adults aged 15-49 have HIV prevalence rates of 19.2% (18.4-20%) (24). Therefore, 
patients whom are HIV exposed may be over represented in the South African context. Further 
sub-analysis of patients with HIV was not performed in this study. 
 
Jeena et al conducted a study in Durban, Kwazulu Natal in 1994 and found that patients with 
acute gastroenteritis, acute respiratory tract infections and protein energy malnutrition had UTI 
co-infection rates of 20-50%, 11-22% and 23-44% respectively (25). Fifty-four patients with 
confirmed UTI were retrospectively studied and concurrent illness was described. However, 
no statistical analysis was performed. Similar rates of infection were found amongst 
malnourished children in Turkey as 30% of the children had concurrent UTI (26). Kala et al 
found similar results with UTI being diagnosed in 34.7% of patients admitted with protein 
energy malnourishment (27). This is contrasted against the data found in the present study 
demonstrating that UTI was less likely for severe acute malnutrition (previously termed protein 
energy malnutrition) and lower respiratory tract infections.  
 
Shaikh et a conducted a study at the Children’s Hospital of Pittsburgh, Pennsylvania USA and 
showed that children with Enterococcus species, Klebsiella species and Pseudomonas 
auruginosa with significantly less likely to display pyuria than children with E. coli (OR of 0.14, 
0.34 and 0.19 respectively). This should be noted in cases were clinical suspicion if UTI is 
high so that early commencement of antibiotics is not delayed (28). 
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In this study, patients with UTI were statistically more likely to be lost to follow up (p=0.0) 
despite having received dates for outpatient department clinics and ultrasound imaging. The 
reasons for this are multifactorial: delay in accessing NHLS urine microscopy results, a busy 
emergency unit and patient financial reasons (e.g. not having transport to attend follow up 
appointments or no contact details so that follow up can be arranged) and likely reflect larger 
social challenges in South Africa presently. 
 
Limitations to this study were that the method of sample collection was a convenience sample. 
Therefore, inherently, patients with urine samples sent to the NHLS were potentially missed 
and not enrolled. Additionally, patients younger than 3 months old are systemically screened 
for potential sources of sepsis and through inclusion bias skew the results towards this age 
demographic. It is also noted that there may not be a clinical suspicion of UTI but attending 
clinicians opt to rule out UTI when managing younger patients. A large proportion of urine 
samples (34/27.6%) had mixed growth. These urine samples were not repeated and, 
therefore, potential true UTI were missed. Factors predisposing to mixed growth/contaminated 
urine cultures are patients < 6months old and uncircumcised male infants (29). In our setting 




We found that 23.6% of the patients had a culture confirmed UTI. Patients with severe acute 
malnutrition and acute respiratory tract infections were less likely to develop UTI. HIV 
exposure (this group is likely to over represented in the South African setting because of our 
high HIV prevalence rates) and urine dipsticks were statistically significant for correlating with 
culture confirmed UTI. These factors can be used to guide attending health professionals in 
whom to screen and initiate empiric antibiotic therapy for UTI.  
 
Considering that 27.6% samples yielded a mixed growth on urine culture, further research is 
need to better understand these factors and their respective impact on developing UTI. Risk 
factors for antibiotic resistance in UTI also needs further exploration. 
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Chapter 4: Conclusion – a Unifying Discussion 
 
UTI is a commonly encountered problem in the paediatric patient presenting with fever. There 
is presently a paucity of South African data on paediatric urinary tract infections. In order to 
provide local insights into UTI, two studies were conducted with the aim of providing contextual 
data compared to international trends. The following issues were examined: 
1) The uropathogens found in urine cultures (viral pathogens were not assessed) in a 
retrospective cohort of urine cultures and in a prospective cohort of children presenting 
to the emergency room at Tygerberg Hospital. 
2) The associated antibiogram profile of significant bacterial urine cultures in community, 
hospital associated and hospital acquired infections. 
3) The factors associated with culture positive UTI in children where clinicians sent urine 
cultures as part of the management protocol for febrile infants and in those whom UTI 
was suspected. 
 
The organism profile is shifting away from E. coli supremacy with K. Pneumoniae being 
another important uropathogen causing UTI; accounting for 50.7% and 22.7% of infections 
respectively. Furthermore, in keeping with international data trends, E. coli exhibited 
resistance rates to amoxicillin, co-amoxiclavulanic acid and TMP/SMX of 90.8%, 38% and 
71.8% respectively. This relevant as these drugs are used in primary care facilities for the 
empiric treatment of community UTI. K. pneumoniae represented 72% of ESBL producers; 
25.3% of these infections were derived from the community setting. The current hospital 
antibiotic guideline for hospital acquired infection is the use of piperacillin-tazobactam and 
amikacin. The evolution of the organism profile is not unexpected and the role of Klebsiella 
ESBL infection in hospital acquired infection is becoming the norm rather than the exception. 
Current international studies have shown that recent hospitalization (in the last 6 months), 
underlying urinary tract structural anomalies and antibiotic exposure are significant risk factors 
for acquiring inherently resistant urine microbials. 
 
A notable finding is the high rate of contaminated urine cultures in both studies. This clearly 
illustrates the issues around the importance of sterile urine sample collection. Mixed cultures 
lead to the added laboratory costs and inherent morbidity in those patients in whom true cases 
of UTI is missed. Catheter specimens are time consuming and invasive. Presently, studies 
are evaluating the quality of perineal bag specimens and alternative techniques for urine 
collection. 
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A major strength of the retrospective cohort was the inclusion of children with hospital 
associated and hospital acquired infection, in contrast to the prospective cohort that assessed 
only community acquired infection. Assessment of the antibiotic profile of the organism 
population allowed us to test current empiric antibiotic management protocols against local 
and international data.  
 
In the prospective cohort of children, 23% of urine cultures sent to the laboratory culture a 
confirmed pathogen.  This may suggest strong screening protocols and appropriate request 
for UTI in suspected cases. Furthermore, one must consider that empiric antibiotic 
administration at referral clinics and in the emergency unit may reduce the yield of positive 
cultures. The rates of positive culture in our context is substantially higher than international 
data and suggests that we are not be screening enough patients. Leukocyte esterase and 
nitrates on urine dipstick have high sensitivity and specificity for positive urine culture. 
However, physicians may still need to send urine samples to the laboratory for microscopy in 
cases where clinical suspicion of UTI is high and urine dipstick is normal. 
 
It was also shown that male patients <3months old, HIV exposure and urine [dipstick] 
leukocyte esterase and nitrates were associated with positive urine cultures. It should be noted 
that patients who are HIV exposed are over represented in South Africa. Patients presenting 
with LRTI as their primary diagnosis were less likely to have concurrent UTI. The results from 
the retrospective study show statistically significant data on the impact of HIV positive status 
on acquiring UTI and resistant organisms. This will need further research examining the true 
role that HIV infection plays. 
 
The data found in this dissertation shows that the organism and resistance profile mirrors that 
of international studies. This data can be used to guide clinicians as to patients presenting 
with UTI, antibiotic choices when empirically treating UTI and potential risk factors for resistant 
organisms. Current literature suggests that prior antibiotic exposure has significant impact on 
[negatively] selecting for resistant uropathogens. Patients who have risk factors for resistant 
organsism should be considered for empiric therapy ith piptazobatem and amikacin. 
Therefore, clinicians must exercise for caution in antibiotic prescription practices to not 
exacerbate this evolving problem. 
 
Due to the paucity of South African data on paediatric UTI, further research is required to 
further explore risk factors for UTI and the development of resistance in our clinical context. 
The focus should be on the influence of HIV, co-morbid conditions and antibiotic exposure on 
UTI. In the interim, yearly audits of urine cultures and the respective antibiogram, sent to the 
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Appendix A: 
Informed Individual Consent form (study “Factors Impacting Positive Bacterial and 
Fungal Urinary Tract Infections in patients (0-5 years) Attending a Paediatric 





PARTICIPANT INFORMATION LEAFLET AND CONSENT FORM 
 
 
TITLE OF THE RESEARCH PROJECT: 
 




PRINCIPAL INVESTIGATOR: Dr. S Irusen 
 
ADDRESS: Department Paediatrics 
Tygerberg Hospital 









You and your child are being invited to take part in a research project.  Please take some time 
to read the information  which will explain the details of this project.  Please ask questions 
about any part of this project that you do not fully understand.  It is very important that you are 
satisfied that you clearly understand what this research is about and how you could be 
involved.  Your participation is entirely voluntary and you are free to refuse.  If you say no, 
this will not affect you negatively in any way whatsoever.  You are also free to withdraw from 
the study at any point, even if you do agree to take part at this stage. 
 
This study has been approved by the Health Research Ethics Committee at Stellenbosch 
University and will be conducted according to the ethical guidelines and principles of the 
international Declaration of Helsinki, South African Guidelines for Good Clinical Practice and 
the Medical Research Council (MRC) Ethical Guidelines for Research. 
 
Why are we asking you to participate? 
 
You and your child have been invited to participate in this study, because your child had his/her 
urine sent to the hospitals laboratory to see if there is infection in the bladder or kidneys. All 
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children, in G-ground, Tygerberg Hospital, that have urine sent for testing will be invited to 
take part in this study. 
 
What is this research study all about? 
We know that bladder and kidney infections are common in young girls and boys. The only 
way we can be sure that a child has such an infection is by sending the urine to the 
laboratory. Even then it can difficult to be sure that the diagnosis was made properly. We 
want to see when doctors suspect bladder and kidney infections in children and why they 
send urine. We also want to see what things influence a positive uine result. 
 
What will your responsibilities be? 
 
You and your child will not be expected to perform any tasks or undergo any additional 
procedures as part of this study. You will be asked a few questions and your blood and urine 
results and ultrasound images will be looked at.   
 
Will you benefit from taking part in this research? 
 
There is no direct benefit to you for taking part in this study, but the information from this study 
will help us plan how to take care of children with kidney and bladder infections in the future. 
 
Are there in risks involved in your taking part in this research? 
 
There are no direct risks involved in participating in this study.  There will be no additional 
medical procedures or treatment given.   Taking part or not taking part will not affect the 
medical treatment of your child.  Tests are part of normal care and are routinely done whether 
you take part in the study or not. All information gathered will be kept confidential and 
anonymous. 
 
If you do not agree to take part, what alternatives do you have? 
You are not forced to participate in this study.  If you refuse there will be no change in how 
you are cared for here at the hospital.   
 
Who will have access to your medical records? 
 
The investigators that will have access your child’s medical records and Road-to-Health 
Booklet are all doctors employed at Tygerberg Hospital in the Department of Paediatrics.  They 
include . All the information we collect will be 
treated as confidential.  No names or hospital numbers will be placed on the information sheet 
used for collection. The Health Research Ethics Committee may inspect the records to 
ensure that the research is being done correctly and does not harm you. 
 
Will you be paid to take part in this study and are there any costs involved? 
 
No, you will not be paid to take part in the study. Participation in the study is free of charge. 
 
 You can contact  if you have any further queries or 
encounter any problems. 
 You can contact the Health Research Ethics Committee at  if you have 
any concerns or complaints that have not been adequately addressed by your study 
doctor. 
 You will receive a copy of this information and consent form for your own records. 
 





Declaration by participant 
 
By signing below, I …………………………………..…………. agree to take part in a research 
study entitled Paediatric bacterial urinary trat infections in the South African context. 
 
I declare that: 
 
 I have read or had read to me this information and consent form and it is written 
in a language with which I am fluent and comfortable. 
 I have had a chance to ask questions and all my questions have been properly 
answered. 
 I understand that taking part in this study is voluntary and I have not been 
pressurised to take part. 
 I may choose to leave the study at any time and will not be penalised or prejudiced 
in any way. 
 
 




 ...................................................................  ...........................................................  





Declaration by investigator 
 
I (name) ……Dr. S. Irusen………………………………..……… declare that: 
 
 I explained the information in this document to ………………………………….. 
 I encouraged her to ask questions and took adequate time to answer them. 
 I am satisfied that she adequately understands all aspects of the research, as 
discussed above 
 I did/did not use an interpreter.  (If an interpreter is used then the interpreter must 
sign the declaration below. 
 
 
Signed at (place) ......................…........……… on (date) …………....………………… 
 
 
 ...................................................................  ...........................................................  




Declaration by Interpreter 
 
I (name) ……………………………………………..……… declare that: 
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 I assisted the investigator (name) …………..……………………. to explain the 
information in this document to (name of participant) 
……………..…………………………….. using the language medium of 
Afrikaans/Xhosa. 
 We encouraged her to ask questions and took adequate time to answer them. 
 I conveyed a factually correct version of what was related to me. 
 I am satisfied that the participant fully understands the content of this informed 
consent document and has had all her questions satisfactorily answered. 
 
 




 ...................................................................  ...........................................................  
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Appendix B 
Data Collection Sheet (study “Factors Impacting Positive Bacterial and Fungal Urinary 
Tract Infections in patients (0-5 years) Attending a Paediatric Emergency ward in a 
Tertiary Care Hospital in the Western Cape, South Africa”) 
 
RESEARCH QUESTION 2: Paediatric UTI in children 0-5years: Data Collection sheet 
 
 
Parental consent obtained: __________ 
Demographic Data 
1. Date of Birth/Age: ___________ 
2. Sex:  Male  Female 
3. Weight and height: _________________ 
4. Reason urine sample obtained: ______________________________ 
Symptoms: 






o Loss of Appetite 
Signs: 
o Suprapubic pain 
o Flank pain 
o Renal angle tenderness 
o oedema 
Comorbid Medical condition: 
5. Please specify:  
o Protein Energy Malnutrition 
o Lower Respiratory Tract infection 
o Tuberculosis 
o Acute Gastro-entertis 
o Meningitis 
o Sepsis (unspecified) 
o Other 
6. HIV exposed: Yes/No 
7. HIV status: 
o HIV test not done 
o HIV positive 
i. Viral load  ________ 
ii. CD4 count  ________ 
iii. ARV’s  Yes/No 




Stellenbosch University  https://scholar.sun.ac.za
44 
Medical History: 
8. Previous UTI (when): Yes/No _______________ 
9. ANY antibiotic exposure in previous year: Yes/No 
10. If yes, type and duration of antibiotic:  
o Penicillin __________________________ 
o Cephalosporin ______________________ 
o Aminoglycoside _____________________ 
o Carbapenem ________________________ 
o Other ______________________________ 
11. IMCI antibiotics: Yes/No 
12. ON antibiotics before/during urine sample taken: Yes/No 
13. If yes, type and duration of antibiotic:  
o Penicillin __________________________ 
o Cephalosporin ______________________ 
o Aminoglycoside _____________________ 
o Carbapenem ________________________ 
o Other ______________________________ 
Investigations: 








15. Urine Sampling method: 
o Mid-stream urine sample 
o Suprapubic aspiration 
o Sterile in-out urine catheter 
16. FBC:  WCC _________ Hb _________ Plt _________ 
17. Chemistry: Urea _________ Creat _________ PCT _________ CRP _________ 
18. Microbiology:  
o Leukocytes:  
 _________________________________________ 
o Erythrocytes:  _________________________________________ 
o Other:   _________________________________________ 
o Organsim:  _________________________________________ 
o Antibiotic Profile:  _________________________________________ 
19. Imaging: 
o Renal ultrasound:  _________________________________________ 
o Other (e.g DMSA): 
 _________________________________________ 
20. Did patients follow up for renal appointments/imaging or lost to follow up? 
________________________________________________________________
___ 
21. If No, was G ground staff alerted: Yes/No 
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